Investment analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report released on Monday. The firm set a “hold” rating on the stock.
Milestone Scientific Stock Performance
Shares of NYSE MLSS opened at $0.97 on Monday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35. The firm has a market cap of $74.91 million, a price-to-earnings ratio of -9.70 and a beta of 0.89. The stock’s 50-day simple moving average is $0.78 and its 200-day simple moving average is $0.69.
Milestone Scientific (NYSE:MLSS – Get Free Report) last announced its earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $2.25 million for the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
- Five stocks we like better than Milestone Scientific
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- What is the Shanghai Stock Exchange Composite Index?
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- How to Buy Cheap Stocks Step by Step
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.